Filter by: Subject
Now showing items 1-5 of 1
Adalimumab (1) |
Análisis costo-beneficio (1) |
Eficacia (1) |
Espondilitis anquilosante (1) |
Factor de necrosis tumoral alfa (1) |
Adalimumab (1) |
Análisis costo-beneficio (1) |
Eficacia (1) |
Espondilitis anquilosante (1) |
Factor de necrosis tumoral alfa (1) |